Clinical Trials Browser

OTHER × Glioblastoma × CPG-oligonucleotide × Clear all

NCT00190424 2012-12-13

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

Phase 2 Completed

Glioblastoma